Joshua S. Prince
Chief Operating Officer · Vistagen Therapeutics, Inc.
Individual
- 2025
- Apr 10, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Joshua S. Prince's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BVF PARTNERS L P - $173.67M in KYMR purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
- Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Joshua S. Prince?
Joshua S. Prince is a corporate insider, tracked as Chief Operating Officer of Vistagen Therapeutics, Inc. (VTGN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Joshua S. Prince last file a Form 4?
The most recent primary Form 4 on record is dated 10 April 2026, one of 2 filings going back to 2025.
